Selective targeting of α4β1 integrin attenuates murine graft versus host disease

Leukemia. 2020 Nov;34(11):3100-3104. doi: 10.1038/s41375-020-0786-0. Epub 2020 Mar 9.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers
  • Disease Models, Animal
  • Disease Susceptibility*
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / etiology*
  • H-2 Antigens / genetics
  • H-2 Antigens / immunology
  • Hematopoietic Stem Cell Transplantation
  • Integrin alpha4beta1 / antagonists & inhibitors*
  • Integrin alpha4beta1 / genetics
  • Integrin alpha4beta1 / metabolism
  • Mice
  • Molecular Targeted Therapy*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Transplantation, Homologous

Substances

  • Biomarkers
  • H-2 Antigens
  • Integrin alpha4beta1